Anixa Biosciences Statistics

Total Valuation

FRA:CY71 has a market cap or net worth of EUR 130.30 million. The enterprise value is 115.64 million.

Market Cap	130.30M
Enterprise Value	115.64M

Important Dates

The next estimated earnings date is Friday, January 9, 2026.

Earnings Date	Jan 9, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	32.92M
Shares Outstanding	n/a
Shares Change (YoY)	+2.02%
Shares Change (QoQ)	+0.85%
Owned by Insiders (%)	5.40%
Owned by Institutions (%)	16.63%
Float	31.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	9.67
P/TBV Ratio	8.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-11.90
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.45, with a Debt / Equity ratio of 0.01.

Current Ratio	8.45
Quick Ratio	7.76
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -62.15% and return on invested capital (ROIC) is -41.00%.

Return on Equity (ROE)	-62.15%
Return on Assets (ROA)	-36.95%
Return on Invested Capital (ROIC)	-41.00%
Return on Capital Employed (ROCE)	-76.92%
Revenue Per Employee	n/a
Profits Per Employee	-1.94M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +26.92% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+26.92%
50-Day Moving Average	3.45
200-Day Moving Average	2.82
Relative Strength Index (RSI)	62.22
Average Volume (20 Days)	484

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.28

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-10.48M
Pretax Income	-9.81M
Net Income	-9.72M
EBITDA	n/a
EBIT	-10.48M
Earnings Per Share (EPS)	-0.30

Full Income Statement

Balance Sheet

The company has 14.01 million in cash and 186,205 in debt, giving a net cash position of 13.83 million.

Cash & Cash Equivalents	14.01M
Total Debt	186,205
Net Cash	13.83M
Net Cash Per Share	n/a
Equity (Book Value)	13.47M
Book Value Per Share	0.44
Working Capital	13.45M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-5.98M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:CY71 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.02%
Shareholder Yield	-2.02%
Earnings Yield	-7.46%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1